Standardized Uptake Value (SUV)
Back to FDG-PET
QIBA FDG-PET/CT Standardized Uptake Value (SUV) Technical Subcommittee
The objective of this subcommittee is to define how to calculate SUV in a consistent manner regardeless of manufacturer, model and version of scanner and workstation.
Completed:
- Collected DICOM PET/CT images of the same reference phantom from scanners from GE, Philips, Siemens
- Image data collated and compared to DICOM header information
- Collected answers from vendors to questionnaires along with other submitted SUV calculation documents
- Described generalized SUV calculation method with vendor-specific variants
The previously described objective of building a common reference DICOM test image that can be generated by each scanner and read on PET DICOM display stations to check information fidelity is the subject of the separate University of Washington Digital Reference Object (DRO) project (described in the 12-Month Final Project Report).
SUV Calculation
- Vendor-neutral pseudo-code for SUV calculation - updated 20170920 to correct swapped Rescale Slope/Intercept - changes from 20091106 tracked
- Vendor-neutral pseudo-code for SUV calculation - extracted "happy path only" - for clarity (BQML, no private data elements required, series time is OK) - updated 20170920 to correct swapped Rescale Slope/Intercept
Letter to vendors requesting detailed SUV computation description
- Media:QIBA_FDG_Vendor_SUV_20081103_DAC.doc Letter sent to vendors
- Media:QIBA_FDG_Vendor_SUV_20081103_DAC_JTY.doc Letter with additional questions from Jeff Yap
Vendor responses on SUV computation
- Philips - Media:QIBA_FDG_Vendor_SUV_Philips.doc
Subcommittee Call Summaries
SUV
- 11.05.2009 FDG-PET/CT SUV Subcommittee Call Summary
- 09.30.2009 FDG-PET/CT SUV Subcommittee Call Summary
- 08.06.2009 FDG-PET/CT SUV Subcommittee Call Summary
DRO
- 04.17.2009 FDG-PET/CT DRO Subcommittee Call Summary
- 03.27.2009 FDG-PET/CT DRO Subcommittee Call Summary
- 03.13.2009 FDG-PET/CT DRO Subcommittee Call Summary
SUV Subcommittee Members
- Paul Kinahan, PhD, Subcommittee Co-chair <kinahan@u.washington.edu>
- David Clunie, MBBS, Subcommittee Co-chair <dclunie@radpharm.com>
- Ronald Boellaard, PhD <r.boellaard@vumc.nl>
- Michael Casey, PhD <michael.e.casey@siemens.com>
- Paul E. Christian <Paul.Christian@hci.utah.edu>
- Patricia E. Cole, PhD, MD <patriciaellencole@gmail.com>
- Simon DeBruin, MSEE <sdebruin@segamicorp.com>
- John M. Hoffman, MD <john.hoffman@hci.utah.edu>
- Steve Kohlmyer <Steve.Kohlmyer@med.ge.com>
- Piotr Maniawski <piotr.maniawski@philips.com>
- Dennis Nelson, PhD <dnelson@mimvista.com>
- Eric S. Perlman, MD <perlman@radpharm.com>
- Ling X. Shao, PhD, <ling.shao@philips.com>
- John G. Wolodzko, PhD <wolodzko@radpharm.com>
- Jeffrey Yap, PhD <Jeffrey_Yap@dfci.harvard.edu>
- Brian Zimmerman, PhD <bez@nist.gov>